Filing Details
- Accession Number:
- 0001086222-20-000156
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-26 16:10:18
- Reporting Period:
- 2020-03-03
- Accepted Time:
- 2020-05-26 16:10:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1086222 | Akamai Technologies Inc | AKAM | Services-Business Services, Nec (7389) | 043432319 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1767894 | J Edward Mcgowan | C/O Akamai Technologies, Inc. 145 Broadway Cambridge MA 02142 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-05-21 | 3,208 | $101.00 | 14,251 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Acquisiton | 2020-03-03 | 5,538 | $0.00 | 5,538 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,538 | 2023-03-06 | No | 4 | A | Direct |
Footnotes
- Sale was made pursuant to a Rule 10b5-1 trading plan.
- Vesting of such RSUs is dependent on the relative cumulative total shareholder return of Akamai's common stock as compared to the S&P 500 Information Technology Index for 2020, 2021 and 2022. To the extent the company's total shareholder return exceeds specified target percentile rankings within such index, the RSUs will vest in full on the date the company's financial results for 2022 are certified. Amount reported is target amount issuable; maximum amount issuable is 200% of target amount.